Insomnia Linked to Shorter Telomeres Than Other Sleep Disorders
A new study finds insomnia patients show significantly shorter telomeres than those with RLS or sleep apnea, hinting at accelerated cellular aging.
Summary
Researchers at Erciyes University measured telomere length in 94 patients across four sleep disorder groups — narcolepsy, insomnia, restless legs syndrome (RLS), and obstructive sleep apnea (OSAS) — plus 22 healthy controls. While no group differed significantly from healthy controls, insomnia patients showed notably shorter telomeres than both RLS and OSAS patients. Telomere length, a key marker of cellular aging, shortens as cells divide and accumulate damage over time. The finding suggests insomnia may accelerate biological aging more than other sleep conditions, potentially raising risk for age-related diseases. The study used rtPCR telomere measurement in adults aged 18–55 with no substance use, providing a relatively clean comparison. These results add to a limited and inconsistent body of literature on sleep and cellular aging.
Detailed Summary
Sleep disturbances are increasingly recognized as contributors to accelerated aging, but which specific disorders pose the greatest cellular risk has remained unclear. Telomere length — the protective caps on chromosomes that shorten with age and stress — offers a measurable window into biological aging, making it a valuable biomarker for comparing disease burden across conditions.
This Turkish study enrolled 116 participants, including 94 patients diagnosed with one of four sleep disorders: narcolepsy (n=31), insomnia (n=20), restless legs syndrome (n=21), or obstructive sleep apnea syndrome (n=22), alongside 22 healthy controls. All participants were adults aged 18–55 with no tobacco, alcohol, or substance dependence, helping to limit confounders. Telomere lengths were quantified via real-time PCR (rtPCR), a widely validated method.
The headline finding was not between patients and healthy controls — no significant differences emerged there — but within the patient groups themselves. Insomnia patients had significantly shorter telomeres than both RLS patients (p=0.014) and OSAS patients (p=0.012), with an overall group effect of F=4.405, p=0.002. Narcolepsy patients were not significantly different from other groups.
These results suggest that insomnia, characterized by chronic difficulty initiating or maintaining sleep, may impose a uniquely high cellular aging burden compared to other sleep disorders. Chronic sleep loss is known to elevate oxidative stress and inflammation — both well-established drivers of telomere attrition. The lack of difference versus healthy controls may reflect the relatively young sample or modest group sizes.
Caveats include the small per-group sample sizes, a cross-sectional design that cannot establish causation, and the absence of longitudinal follow-up to track telomere dynamics over time. Nonetheless, the study raises important questions about insomnia as a potential accelerant of biological aging warranting closer clinical attention.
Key Findings
- Insomnia patients had significantly shorter telomeres than RLS patients (p=0.014) and OSAS patients (p=0.012).
- No significant telomere length differences were found between any sleep disorder group and healthy controls.
- Narcolepsy patients showed no significant telomere differences compared to other sleep disorder groups.
- Findings suggest insomnia may carry a higher risk for accelerated cellular aging than other sleep disorders.
- Telomere length was measured via rtPCR in 116 adults aged 18–55 free of substance use.
Methodology
Cross-sectional study of 116 participants (94 patients, 22 healthy controls) diagnosed per ICSD-3 criteria across four sleep disorder groups. Telomere length was quantified using real-time PCR (rtPCR) from peripheral blood samples. Participants were aged 18–55 with no tobacco, alcohol, or substance dependence to minimize confounding.
Study Limitations
Small per-group sample sizes (20–31 patients per group) limit statistical power and generalizability. The cross-sectional design prevents causal inference about whether insomnia causes telomere shortening or vice versa. The absence of significant differences versus healthy controls may reflect the relatively young cohort or insufficient sample size to detect smaller effects.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.